Literature DB >> 1628222

Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases.

G Perry1, P Richey, S L Siedlak, P Galloway, M Kawai, P Cras.   

Abstract

The extracellular matrix protein heparin sulfate proteoglycans (HSPG) has been found in the neurofibrillary pathology of Alzheimer disease. This study was performed to determine if similar proteoglycans might be present in the fibrillary inclusions of other neurodegenerative diseases. Basic fibroblast growth factor (bFGF) binding to heparinase sensitive sites was used as an assay for HSPGs. We found that the inclusions of Pick and Parkinson diseases as well as progressive supranuclear palsy contained heparinase sensitive bFGF binding sites while the inclusions of diffuse Lewy body disease lacked bFGF binding sites. These findings indicate that HSPG's interactions and possible role in the formation of intraneuronal inclusions are not limited to Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628222     DOI: 10.1016/0006-8993(92)90074-j

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

Review 2.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

3.  Glycosaminoglycans have variable effects on α-synuclein aggregation and differentially affect the activities of the resulting amyloid fibrils.

Authors:  Surabhi Mehra; Dhiman Ghosh; Rakesh Kumar; Mrityunjoy Mondal; Laxmikant G Gadhe; Subhadeep Das; Arunagiri Anoop; Narendra N Jha; Reeba S Jacob; Debdeep Chatterjee; Soumik Ray; Nitu Singh; Ashutosh Kumar; Samir K Maji
Journal:  J Biol Chem       Date:  2018-06-29       Impact factor: 5.157

4.  Characterization of heparin-induced glyceraldehyde-3-phosphate dehydrogenase early amyloid-like oligomers and their implication in α-synuclein aggregation.

Authors:  Clarisa M Torres-Bugeau; César L Ávila; Rita Raisman-Vozari; Dulce Papy-Garcia; Rosangela Itri; Leandro R S Barbosa; Leonardo M Cortez; Valerie L Sim; Rosana N Chehín
Journal:  J Biol Chem       Date:  2011-12-01       Impact factor: 5.157

Review 5.  Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays.

Authors:  Niccolo Candelise; Matthias Schmitz; Katrin Thüne; Maria Cramm; Alberto Rabano; Saima Zafar; Erik Stoops; Hugo Vanderstichele; Anna Villar-Pique; Franc Llorens; Inga Zerr
Journal:  Transl Neurodegener       Date:  2020-01-17       Impact factor: 8.014

6.  The Non-Fibrillating N-Terminal of α-Synuclein Binds and Co-Fibrillates with Heparin.

Authors:  Line K Skaanning; Angelo Santoro; Thomas Skamris; Jacob Hertz Martinsen; Anna Maria D'Ursi; Saskia Bucciarelli; Bente Vestergaard; Katrine Bugge; Annette Eva Langkilde; Birthe B Kragelund
Journal:  Biomolecules       Date:  2020-08-16

7.  Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology.

Authors:  Youqi Tao; Yunpeng Sun; Shiran Lv; Wencheng Xia; Kun Zhao; Qianhui Xu; Qinyue Zhao; Lin He; Weidong Le; Yong Wang; Cong Liu; Dan Li
Journal:  Nat Commun       Date:  2022-07-22       Impact factor: 17.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.